MedPath

Lyrica

These highlights do not include all the information needed to use LYRICA safely and effectively. See full prescribing information for LYRICA. LYRICA (pregabalin) Capsules, CVInitial U.S. Approval: 2004

Approved
Approval ID

aac6c6a4-17a3-4643-bc89-db7259aca03a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Jan 24, 2012

Manufacturers
FDA

Rebel Distributors Corp

DUNS: 118802834

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

PREGABALIN

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code42254-134
Application NumberNDA021724
Product Classification
M
Marketing Category
C73594
G
Generic Name
PREGABALIN
Product Specifications
Route of AdministrationORAL
Effective DateApril 22, 2011
FDA Product Classification

INGREDIENTS (13)

LACTOSE MONOHYDRATEInactive
Code: EWQ57Q8I5X
Classification: IACT
PREGABALINActive
Quantity: 225 mg in 1 1
Code: 55JG375S6M
Classification: ACTIB
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
TALCInactive
Code: 7SEV7J4R1U
Classification: IACT
GELATINInactive
Code: 2G86QN327L
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT
SODIUM LAURYL SULFATEInactive
Code: 368GB5141J
Classification: IACT
FERRIC OXIDE REDInactive
Code: 1K09F3G675
Classification: IACT
POTASSIUM HYDROXIDEInactive
Code: WZH3C48M4T
Classification: IACT
SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
SHELLACInactive
Code: 46N107B71O
Classification: IACT
FERROSOFERRIC OXIDEInactive
Code: XM0M87F357
Classification: IACT
PROPYLENE GLYCOLInactive
Code: 6DC9Q167V3
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Lyrica - FDA Drug Approval Details